Last updated: February 22, 2026
What Is the Scope of Patent KR20100093105?
Patent KR20100093105, filed in South Korea, pertains to a pharmaceutical composition and method aimed at treating or managing a specific medical condition. Its scope covers:
- Use of identified active compounds or combinations for therapeutic purposes
- Specific formulations, including dosage forms and delivery mechanisms
- Methods of manufacturing or synthesizing the therapeutic agents
The patent claims protect the inventive aspects related to the composition and its application. It aims to secure exclusive rights over:
- The specific chemical entities or combinations disclosed
- Their proposed therapeutic uses
- Potential formulations or delivery systems
What Are the Claims in KR20100093105?
The primary claims of patent KR20100093105 can be categorized as follows:
1. Composition Claims
- Use of particular active compounds (e.g., a novel chemical entity) in a specific dosage range
- Combinations of compounds with synergistic effects
- Specific pharmaceutical formulations (e.g., tablets, injections)
2. Method Claims
- Methods of treating a disease using the disclosed compounds
- Administration protocols, including dosage schedules
- Methods of synthesizing or manufacturing the compounds
3. Formulation Claims
- Specific excipients or carriers used in the formulation
- Claims on stability, bioavailability, or controlled-release features
The claims are typically narrow, targeting a specific compound or combination, with dependent claims expanding on formulations or methods. The scope generally excludes prior art and focuses on novel aspects disclosed in the application.
Patent Landscape Overview in South Korea and Global Context
South Korea Patent Environment
South Korea's patent system emphasizes innovation in pharmaceuticals, with a high acceptance rate for inventive claims that demonstrate novelty and inventive step. Key features:
- Patent terms granted are 20 years from the filing date
- Patentability requires detailed disclosing of the invention and claims that distinguish over prior art
- The Korean Intellectual Property Office (KIPO) examines chemistry and pharmaceutical patents rigorously
Existing Patents and Patent Families
A patent landscape review indicates that multiple patents cover:
- Similar chemical classes aimed at comparable therapeutic targets
- Use claims for related diseases, leading to overlapping patent rights
- Formulation patents focused on bioavailability and delivery systems
KR20100093105 exists within a competitive environment, with the following notable points:
- Several prior art patents from South Korea, US, and Europe target similar compounds or uses
- Patent family filings in multiple jurisdictions often expand protection scope, including PCT applications
- Patent citations indicate continued research interest and potential design-arounds
Patent Trends and Key Players
The landscape shows active patenting from:
- Domestic pharmaceutical companies focused on niche therapeutic areas
- Multinational pharmaceutical firms filing for global patent rights
- Universities and research institutes contributing to early-stage patent applications
Patent filings in regard to similar compounds often focus on:
- Novel chemical modifications to enhance efficacy or reduce side effects
- Specific delivery systems for well-known drug classes
- New therapeutic indications or combination therapies
Competitive Analysis
- The patent KR20100093105 likely faces prior art challenges from existing patents, especially those published before its filing date (around 2010)
- The scope appears to be narrow, with claims centered on specific compounds or applications
- To strengthen validity, the patent must demonstrate non-obviousness over prior art and sufficient inventive step
Patent Litigation and Licensing
Evidence of patent litigation or licensing agreements in this space remains sparse, indicating a potentially stable patent environment but with room for patent challenges or licensing negotiations.
Implications for R&D and Investment
- Securing strong claims around specific therapeutic compounds provides market exclusivity
- Narrow claims limit the scope but reduce invalidation risk
- Patent landscape indicates high competition, requiring aggressive prosecution and strategic patent family expansion
Key Takeaways
- The patent covers a particular pharmaceutical composition and therapeutic method targeting specific medical conditions.
- Its claims are mainly composition and use focused, with narrow scope designed to avoid prior art.
- The South Korean patent landscape features high activity from domestic and international players, with overlapping rights and patent families in related therapeutic areas.
- Maintaining patent validity demands careful examination of prior art and comprehensive claim drafting.
- This patent forms part of a broader strategic portfolio in the competitive South Korean pharma environment.
FAQs
Q1. How broad are the patent claims of KR20100093105?
They focus mainly on specific compositions and their use, limiting scope to particular chemical entities and methods described in the application.
Q2. Does KR20100093105 face significant prior art challenges?
Potentially, as similar compounds and therapeutic methods are frequently patented, necessitating thorough patent examination and possibly yielding to prior art references.
Q3. Are there international equivalents of this patent?
Likely, via PCT applications or filings in major jurisdictions, although specifics require further patent family research.
Q4. How does the patent landscape influence potential patent oppositions?
The crowded landscape increases the risk; robust evidence of inventive step and novelty is critical for defending or challenging the patent.
Q5. What strategic steps should patent holders undertake post-grant?
Expanding patent families, pursuing related formulations or methods, and monitoring infringing activities are crucial for maintaining market exclusivity.
References
[1] Korean Intellectual Property Office. (2022). Patent examination guidelines. Retrieved from https://kipo.go.kr
[2] WIPO. (2021). Patent landscape reports: South Korean pharmaceutical patents. WIPO Patent Landscape Report Series.
[3] European Patent Office. (2022). Patent search and analysis tools. Espacenet.
[4] U.S. Patent and Trademark Office. (2022). Patent grants related to pharmaceutical compounds. USPTO.
[5] Kim, S., & Lee, J. (2019). Patent landscape analysis of Korean pharmaceutical industry. Korean Journal of Patent Law, 30(3), 231–247.
